Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
6.7 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | INS-PEDIATRIC AUTOIMMUNE COVER | Amends the Illinois Insurance Code. Provides that no group or individual policy of accident and health insurance or managed care plan shall deny or delay coverage for medically necessary treatment because the insured, enrollee, or beneficiary previously received any treatment, including the same or similar treatment, for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections or pediatric acute onset neuropsychiatric syndrome, or because the insured, enrollee, or beneficiary has been diagnosed with or receives treatment for an otherwise diagnosed condition. Provides that coverage of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome shall adhere to the treatment recommendations developed by a medical professional consortium convened for the purposes of researching, identifying, and publishing best practice standards for diagnosis and treatment of such disorders or syndrome that are accessible for medical professionals and are based on evidence of positive patient outcomes. Provides that coverage for any form of medically necessary treatment shall not be limited over a lifetime of an insured, enrollee, or beneficiary, unless the patient is no longer benefiting from the treatment, or by policy period. Provides that nothing in the provisions prevents insurers from requesting treatment notes and anticipated duration of treatment and outcomes. Effective immediately. | us/states/il | Illinois General Assembly | 103rd | SB 101 | Illinois SB 101 (103rd) |
|
enacted |
|
3 | 28 | 4 | 2023-01-24 | 2023-06-09 | openstates | ocd-bill/a9d96ed1-debf-4ce1-9928-17c78bb2feec | https://beta.ilga.gov/Legislation/BillStatus?DocNum=101&GAID=17&DocTypeID=SB&LegId=143427&SessionID=112 | 6d3d64b6a7b7791b8e2b1b5cdf8d225a374394d27c0ec88eb56427472ce6c9a8 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Illinois SB 101 (103rd) — INS-PEDIATRIC AUTOIMMUNE COVER
Amends the Illinois Insurance Code. Provides that no group or individual policy of accident and health insurance or managed care plan shall deny or delay coverage for medically necessary treatment because the insured, enrollee, or beneficiary previously received any treatment, including the same or similar treatment, for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections or pediatric acute onset neuropsychiatric syndrome, or because the insured, enrollee, or beneficiary has been diagnosed with or receives treatment for an otherwise diagnosed condition. Provides that coverage of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome shall adhere to the treatment recommendations developed by a medical professional consortium convened for the purposes of researching, identifying, and publishing best practice standards for diagnosis and treatment of such disorders or syndrome that are accessible for medical professionals and are based on evidence of positive patient outcomes. Provides that coverage for any form of medically necessary treatment shall not be limited over a lifetime of an insured, enrollee, or beneficiary, unless the patient is no longer benefiting from the treatment, or by policy period. Provides that nothing in the provisions prevents insurers from requesting treatment notes and anticipated duration of treatment and outcomes. Effective immediately.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
Votes
- Insurance — 14–0 (pass) · lower
- Third Reading — 104–0 (pass) · lower
- Insurance — 10–0 (pass) · lower
- Third Reading — 57–0 (pass) · lower
Sponsors
- Jennifer Gong-Gershowitz — primary (person)
- Laura Fine — primary (person)
- Janet Yang Rohr — cosponsor (person)
- Laura Ellman — cosponsor (person)
- Paul Faraci — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2023-01-24 Filed with Secretary by Sen. Laura Fine
filing - 2023-01-24 First Reading
reading-1 - 2023-01-24 Referred to Assignments
- 2023-01-30 Added as Chief Co-Sponsor Sen. Laura Ellman
- 2023-01-31 Assigned to Insurance
referral-committee - 2023-02-08 Do Pass Insurance; 010-000-000
- 2023-02-08 Placed on Calendar Order of 2nd Reading February 14, 2023
reading-2 - 2023-03-03 Added as Co-Sponsor Sen. Paul Faraci
- 2023-03-10 Second Reading
reading-2 - 2023-03-10 Placed on Calendar Order of 3rd Reading March 21, 2023
- 2023-03-23 Placed on Calendar Order of 3rd Reading ** March 24, 2023
- 2023-03-29 Third Reading - Passed; 057-000-000
passage, reading-3 - 2023-03-30 Arrived in House
introduction - 2023-03-30 Chief House Sponsor Rep. Jennifer Gong-Gershowitz
- 2023-03-30 First Reading
reading-1 - 2023-03-30 Referred to Rules Committee
- 2023-04-11 Assigned to Insurance Committee
referral-committee - 2023-04-17 Added Alternate Co-Sponsor Rep. Janet Yang Rohr
- 2023-04-18 Do Pass / Short Debate Insurance Committee; 014-000-000
- 2023-04-19 Placed on Calendar 2nd Reading - Short Debate
reading-2 - 2023-04-27 Second Reading - Short Debate
reading-2 - 2023-04-27 Placed on Calendar Order of 3rd Reading - Short Debate
- 2023-05-04 Third Reading - Short Debate - Passed 104-000-000
passage, reading-3 - 2023-05-04 Passed Both Houses
- 2023-06-02 Sent to the Governor
executive-receipt - 2023-06-09 Governor Approved
executive-signature - 2023-06-09 Effective Date June 9, 2023
- 2023-06-09 Public Act . . . . . . . . . 103-0059
became-law
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/a9d96ed1-debf-4ce1-9928-17c78bb2feec. Confidence: reported (aggregated from official Illinois legislature records).